Gout and the risk of COVID-19 diagnosis and death in the UK Biobank: a population-based study.

ABSTRACT:

Background

There is a paucity of data on outcomes for people with gout and COVID-19. We aimed to assess whether gout is a risk factor for diagnosis of COVID-19 and COVID-19-related death, and to test for sex- and drug-specific differences in risk.

Methods

We used data from the UK Biobank, which included 15 871 people with gout. We used multivariable-adjusted logistic regression in the following analyses using a case-control study design: to test for an association between gout and COVID-19 diagnosis in the entire UK Biobank cohort (n=459 837); to test for an association between gout and COVID-19-related death in people who were known to have died or survived with COVID-19 (n=15 772); to test for an association between gout and COVID-19-related death in the entire UK Biobank

SUBMITTER: Topless RK 

PROVIDER: S-EPMC8798088 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature